| Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation KJ Ewer, GA O’Hara, CJA Duncan, KA Collins, SH Sheehy, ... Nature communications 4 (1), 2836, 2013 | 351 | 2013 |
| Memory CD8 T cell responses exceeding a large but definable threshold provide long-term immunity to malaria NW Schmidt, RL Podyminogin, NS Butler, VP Badovinac, BJ Tucker, ... Proceedings of the National Academy of Sciences 105 (37), 14017-14022, 2008 | 301 | 2008 |
| Viral vectors as vaccine platforms: deployment in sight CS Rollier, A Reyes-Sandoval, MG Cottingham, K Ewer, AVS Hill Current opinion in immunology 23 (3), 377-382, 2011 | 281 | 2011 |
| A simian replication-defective adenoviral recombinant vaccine to HIV-1 gag JC Fitzgerald, GP Gao, A Reyes-Sandoval, GN Pavlakis, ZQ Xiang, ... The Journal of Immunology 170 (3), 1416-1422, 2003 | 260 | 2003 |
| Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector GA O’Hara, CJA Duncan, KJ Ewer, KA Collins, SC Elias, FD Halstead, ... Journal of Infectious Diseases 205 (5), 772-781, 2012 | 252 | 2012 |
| Prime-Boost Immunization with Adenoviral and Modified Vaccinia Virus Ankara Vectors Enhances the Durability and Polyfunctionality of Protective Malaria CD8+ T … A Reyes-Sandoval, T Berthoud, N Alder, L Siani, SC Gilbert, A Nicosia, ... Infection and immunity 78 (1), 145-153, 2010 | 248 | 2010 |
| Adenoviral vectors persist in vivo and maintain activated CD8+ T cells: implications for their use as vaccines N Tatsis, JC Fitzgerald, A Reyes-Sandoval, KC Harris-McCoy, ... Blood, The Journal of the American Society of Hematology 110 (6), 1916-1923, 2007 | 245 | 2007 |
| Prime-boost vectored malaria vaccines: progress and prospects AVS Hill, A Reyes-Sandoval, G O’Hara, K Ewer, A Lawrie, A Goodman, ... Human vaccines 6 (1), 78-83, 2010 | 240 | 2010 |
| Novel, chimpanzee serotype 68-based adenoviral vaccine carrier for induction of antibodies to a transgene product Z Xiang, G Gao, A Reyes-Sandoval, CJ Cohen, Y Li, JM Bergelson, ... Journal of virology 76 (6), 2667-2675, 2002 | 218 | 2002 |
| DNA vaccines. A Reyes-Sandoval, HCJ Ertl Current molecular medicine 1 (2), 217-243, 2001 | 156 | 2001 |
| Oral vaccination of mice with adenoviral vectors is not impaired by preexisting immunity to the vaccine carrier ZQ Xiang, GP Gao, A Reyes-Sandoval, Y Li, JM Wilson, HCJ Ertl Journal of virology 77 (20), 10780-10789, 2003 | 155 | 2003 |
| CD8+ T effector memory cells protect against liver-stage malaria A Reyes-Sandoval, DH Wyllie, K Bauza, A Milicic, EK Forbes, CS Rollier, ... The Journal of Immunology 187 (3), 1347-1357, 2011 | 146 | 2011 |
| Recombinant viruses as vaccines against viral diseases APD Souza, L Haut, A Reyes-Sandoval, AR Pinto Brazilian Journal of Medical and Biological Research 38, 509-522, 2005 | 137 | 2005 |
| Single‐dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei A Reyes‐Sandoval, S Sridhar, T Berthoud, AC Moore, JT Harty, ... European journal of immunology 38 (3), 732-741, 2008 | 136 | 2008 |
| Evaluation of the safety and immunogenicity of a candidate tuberculosis vaccine, MVA85A, delivered by aerosol to the lungs of macaques AD White, L Sibley, MJ Dennis, K Gooch, G Betts, N Edwards, ... Clinical and Vaccine Immunology 20 (5), 663-672, 2013 | 122 | 2013 |
| Human immunodeficiency virus type 1-specific immune responses in primates upon sequential immunization with adenoviral vaccine carriers of human and simian serotypes A Reyes-Sandoval, JC Fitzgerald, R Grant, S Roy, ZQ Xiang, Y Li, GP Gao, ... Journal of virology 78 (14), 7392-7399, 2004 | 114 | 2004 |
| COVID-19 vaccines: breaking record times to first-in-human trials YC Kim, B Dema, A Reyes-Sandoval npj Vaccines 5 (1), 34, 2020 | 113 | 2020 |
| CpG methylation of a plasmid vector results in extended transgene product expression by circumventing induction of immune responses A Reyes-Sandoval, HCJ Ertl Molecular Therapy 9 (2), 249-261, 2004 | 100 | 2004 |
| Immune responses against a liver-stage malaria antigen induced by simian adenoviral vector AdCh63 and MVA prime–boost immunisation in non-human primates S Capone, A Reyes-Sandoval, M Naddeo, L Siani, V Ammendola, ... Vaccine 29 (2), 256-265, 2010 | 94 | 2010 |
| Rational Zika vaccine design via the modulation of antigen membrane anchors in chimpanzee adenoviral vectors C López-Camacho, P Abbink, RA Larocca, W Dejnirattisai, M Boyd, ... Nature communications 9 (1), 2441, 2018 | 81 | 2018 |
